News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,932 Results
Type
Article (43051)
Company Profile (301)
Press Release (674579)
Multimedia
Podcasts (68)
Webinars (14)
Section
Business (206900)
Career Advice (2125)
Deals (36937)
Drug Delivery (102)
Drug Development (81931)
Employer Resources (173)
FDA (16459)
Job Trends (15158)
News (350948)
Policy (33302)
Tag
Academia (2639)
Accelerated approval (10)
Adcomms (23)
Allergies (96)
Alliances (50526)
ALS (110)
Alzheimer's disease (1460)
Antibody-drug conjugate (ADC) (160)
Approvals (16451)
Artificial intelligence (348)
Autoimmune disease (32)
Automation (19)
Bankruptcy (374)
Best Places to Work (11755)
BIOSECURE Act (20)
Biosimilars (128)
Biotechnology (209)
Bladder cancer (97)
Brain cancer (38)
Breast cancer (372)
Cancer (2924)
Cardiovascular disease (218)
Career advice (1781)
Career pathing (32)
CAR-T (193)
CDC (32)
Cell therapy (522)
Cervical cancer (22)
Clinical research (67432)
Collaboration (1047)
Company closure (3)
Compensation (692)
Complete response letters (24)
COVID-19 (2678)
CRISPR (60)
C-suite (336)
Cystic fibrosis (117)
Data (3033)
Decentralized trials (2)
Denatured (23)
Depression (66)
Diabetes (353)
Diagnostics (6504)
Digital health (26)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (161)
Drug pricing (127)
Drug shortages (29)
Duchenne muscular dystrophy (131)
Earnings (87836)
Editorial (40)
Employer branding (21)
Employer resources (150)
Events (114881)
Executive appointments (860)
FDA (18157)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (954)
Gene editing (136)
Generative AI (28)
Gene therapy (386)
GLP-1 (815)
Government (4590)
Grass and pollen (4)
Guidances (183)
Healthcare (19089)
HIV (41)
Huntington's disease (31)
IgA nephropathy (41)
Immunology and inflammation (155)
Immuno-oncology (9)
Indications (39)
Infectious disease (2856)
Inflammatory bowel disease (156)
Inflation Reduction Act (12)
Influenza (65)
Intellectual property (121)
Interviews (336)
IPO (16719)
IRA (48)
Job creations (3792)
Job search strategy (1504)
Kidney cancer (13)
Labor market (53)
Layoffs (526)
Leadership (21)
Legal (8164)
Liver cancer (79)
Longevity (11)
Lung cancer (406)
Lymphoma (210)
Machine learning (11)
Management (60)
Manufacturing (410)
MASH (92)
Medical device (13653)
Medtech (13658)
Mergers & acquisitions (20951)
Metabolic disorders (869)
Multiple sclerosis (98)
NASH (16)
Neurodegenerative disease (121)
Neuropsychiatric disorders (36)
Neuroscience (2161)
NextGen: Class of 2025 (6696)
Non-profit (4553)
Now hiring (48)
Obesity (437)
Opinion (236)
Ovarian cancer (102)
Pain (108)
Pancreatic cancer (125)
Parkinson's disease (188)
Partnered (22)
Patents (307)
Patient recruitment (169)
Peanut (51)
People (58552)
Pharmaceutical (74)
Pharmacy benefit managers (22)
Phase I (21034)
Phase II (29676)
Phase III (22116)
Pipeline (1656)
Policy (208)
Postmarket research (2597)
Preclinical (8986)
Press Release (66)
Prostate cancer (140)
Psychedelics (37)
Radiopharmaceuticals (260)
Rare diseases (476)
Real estate (6059)
Recruiting (66)
Regulatory (23071)
Reports (51)
Research institute (2385)
Resumes & cover letters (364)
Rett syndrome (9)
RNA editing (9)
RSV (50)
Schizophrenia (91)
Series A (166)
Series B (112)
Service/supplier (13)
Sickle cell disease (61)
Special edition (20)
Spinal muscular atrophy (150)
Sponsored (32)
Startups (3731)
State (2)
Stomach cancer (14)
Supply chain (77)
Tariffs (58)
The Weekly (43)
Vaccines (799)
Venture capital (56)
Weight loss (270)
Women's health (47)
Worklife (16)
Date
Today (107)
Last 7 days (386)
Last 30 days (1900)
Last 365 days (32014)
2025 (17462)
2024 (35807)
2023 (40398)
2022 (51548)
2021 (56153)
2020 (54570)
2019 (47219)
2018 (35639)
2017 (32721)
2016 (32201)
2015 (38236)
2014 (31960)
2013 (27034)
2012 (29271)
2011 (29935)
2010 (28072)
Location
Africa (760)
Alabama (61)
Alaska (7)
Arizona (246)
Arkansas (13)
Asia (39445)
Australia (6438)
California (7520)
Canada (2373)
China (685)
Colorado (323)
Connecticut (321)
Delaware (192)
Europe (85095)
Florida (1128)
Georgia (249)
Hawaii (1)
Idaho (62)
Illinois (653)
India (28)
Indiana (364)
Iowa (17)
Japan (230)
Kansas (110)
Kentucky (30)
Louisiana (15)
Maine (64)
Maryland (1036)
Massachusetts (5616)
Michigan (248)
Minnesota (457)
Mississippi (3)
Missouri (92)
Montana (28)
Nebraska (25)
Nevada (82)
New Hampshire (70)
New Jersey (2096)
New Mexico (29)
New York (2110)
North Carolina (1089)
North Dakota (8)
Northern California (3301)
Ohio (242)
Oklahoma (16)
Oregon (36)
Pennsylvania (1623)
Puerto Rico (17)
Rhode Island (36)
South America (1144)
South Carolina (34)
South Dakota (1)
Southern California (2815)
Tennessee (128)
Texas (1137)
United States (27902)
Utah (223)
Virginia (188)
Washington D.C. (75)
Washington State (644)
West Virginia (4)
Wisconsin (66)
717,932 Results for "dynextechnologies acquired by magellan biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right
July 2, 2025
·
6 min read
Press Releases
Castle Biosciences to Acquire Previse
May 6, 2025
·
4 min read
Press Releases
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
April 3, 2025
·
4 min read
Press Releases
Continuity Biosciences Acquires Focal Medical to Advance Targeted Drug Delivery for Pancreatic Cancer
June 4, 2025
·
4 min read
Press Releases
Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study
July 17, 2025
·
6 min read
Press Releases
Enzo Biochem, Inc. To be Acquired by Battery Ventures in All-Cash Transaction
June 24, 2025
·
7 min read
Press Releases
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction
July 15, 2025
·
13 min read
Press Releases
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
December 12, 2024
·
19 min read
Press Releases
Bloom Burton & Co. Inc. Announces Exercise of Satellos Bioscience Inc. Warrants
May 21, 2025
·
1 min read
Press Releases
LPOXY Therapeutics, Inc. Acquires Key Assets from Xeno Biosciences Inc. to Advance C. difficile Prevention Therapy
January 6, 2025
·
3 min read
1 of 71,794
Next
